Neuroprotection by histone deacetylase-related protein

Molecular and Cellular Biology

Volumn 26, Issue 9, 2006, Pages 3550-3564

  Morrison, Brad E ^a   Majdzadeh, Nazanin ^a   Zhang, Xiaoguang ^a   Lyles, Aaron ^a   Bassel Duby, Rhonda ^b   Olson, Eric N ^b   D'Mello, Santosh R ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; HISTONE DEACETYLASE; HISTONE DEACETYLASE RELATED PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE OVEREXPRESSION; HELA CELL; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL NUCLEUS; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HISTONE DEACETYLASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

ADENOVIRIDAE; ANIMALIA;

EID: 33646265796     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.9.3550-3564.2006     Document Type: Article

References (48)

1. Bolger, T. A., and T. P. Yao. 2005. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci. 25:9544-9553.
2. Borodezt, K., and S. R. D'Mello. 1998. Decreased expression of the metabotropic glutamate receptor-4 gene is associated with neuronal apoptosis. J. Neurosci. Res. 53:531-541.
3. Borras, E., R. Zaragoza, M. Morante, C. Garcia, A. Gimeno, G. Lopez-Rodas, T. Barber, V. J. Miralles, J. R. Vina, and L. Torres. 2003. In vivo studies of altered expression patterns of p53 and proliferative control genes in chronic vitamin A deficiency and hypervitaminosis. Eur. J. Biochem. 270:1493-1501.
4. Boutillier, A. L., E. Triah, and J. P. Loeffler. 2002. Constitutive repression of E2F1 transcriptional activity through HDAC proteins is essential for neuronal survival. Ann. N. Y. Acad. Sci. 973:438-442.
5. Boutillier, A. L., E. Trinh, and J. P. Loeffler. 2003. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J. Neurochem. 84:814-828.
6. Bozyczko-Coyne, D., M. S. Saporito, and R. L. Hudkins. 2002. Targeting the JNK pathway for therapeutic benefit in CNS disease. Curr. Drug Targets CNS Neurol. Disord. 1:31-49.
7. Brunet, A., S. R. Datta, and M. E. Greenberg. 2001. Transcription- dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11:297-305.
8. Buck, S. W., C. M. Gallo, and J. S. Smith. 2004. Diversity in the Sir2 family of protein deacetylases. J. Leukoc. Biol. 75:939-950.
9. Chin, P. C., L. Liu, B. E. Morrison, A. Siddiq, R. R. Ratan, T. Bottiglieri, and S. R. D'Mello. 2004. The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. J. Neurochem. 90:595-608.
10. Coffey, E. T., G. Smiciene, V. Hongisto, J. Cao, S. Brecht, T. Herdegen, and M. J. Courtney. 2002. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J. Neurosci. 22:4335-4345.
11. de Ruijter, A. J., A. H. van Gennip, H. N. Caron, S. Kemp, and A. B. van Kuilenburg. 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370:737-749.
12. D'Mello, S. R., C. Galli, T. Ciotti, and P. Calissano. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90:10989-10993.
13. Ferrante, R. J., J. K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N. W. Kowall, R. R. Ratan, R. Luthi-Carter, and S. M. Hersch. 2003. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23:9418-9427.
14. Graczyk, P. P., A. Khan, G. S. Bhatia, V. Palmer, D. Medland, H. Numata, H. Oinuma, J. Catchick, A. Dunne, M. Ellis, C. Smales, J. Whitfield, S. J. Neame, B. Shah, D. Wilton, L. Morgan, T. Patel, R. Chung, H. Desmond, J. M. Staddon, N. Sato, and A. Inoue. 2005. The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold. Bioorg. Med. Chem. Lett. 15:4666-4670.
15. 2+/calmodulin-dependent protein kinase activity. Neuroscience 57:9-20.
16. Ham, J., C. Babij, J. Whitfield, C. M. Pfarr, D. Lallemand, M. Yaniv, and L. L. Rubin. 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939.
17. Ham, J., A. Eilers, J. Whitfield, S. J. Neame, and B. Shah. 2000. c-Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60:1015-1021.
18. Hetman, M., and A. Gozdz. 2004. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur. J. Biochem. 271:2050-2055.
19. Hockly, E., V. M. Richon, B. Woodman, D. L. Smith, X. Zhou, E. Rosa, K. Sathasivam, S. Ghazi-Noori, A. Mahal, P. A. Lowden, J. S. Steffan, J. L. Marsh, L. M. Thompson, C. M. Lewis, P. A. Marks, and G. P. Bates. 2003. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 100:2041-2046.
20. Johnson, D., S. W. Horsley, D. M. Moloney, M. Oldridge, S. R. Twigg, S. Walsh, M. Barrow, P. R. Njolstad, J. Kunz, G. J. Ashworth, S. A. Wall, L. Kearney, and A. O. Wilkie. 1998. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am. J. Hum. Genet. 63:1282-1293.
21. Keramaris, E., J. L. Vanderluit, M. Bahadori, K. Mousavi, R. J. Davis, R. Flavell, R. S. Slack, and D. S. Park. 2005. c-Jun N-terminal kinase 3 deficiency protects neurons from axotomy-induced death in vivo through mechanisms independent of c-Jun phosphorylation. J. Biol. Chem. 280:1132-1141.
22. Koulich, E., T. Nguyen, K. Johnson, C. Giardina, and S. D'Mello. 2001. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival. J. Neurochem. 76:1188-1198.
23. Kuan, C. Y., and R. E. Burke. 2005. Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr. Drug Targets CNS Neurol. Disord. 4:63-67.
24. Langley, B., J. M. Gensert, M. F. Beal, and R. R. Ratan. 2005. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr. Drug Targets CNS Neurol. Disord. 4:41-50.
25. Legube, G., and D. Trouche. 2003. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4:944-947.
26. Lewanda, A. F., E. D. Green, J. Weissenbach, H. Jerald, E. Taylor, M. L. Summar, J. A. Phillips III, M. Cohen, M. Feingold, W. Mouradian, et al. 1994. Evidence that the Saethre-Chotzen syndrome locus lies between D7S664 and D7S507, by genetic analysis and detection of a microdeletion in a patient. Am. J. Hum. Genet. 55:1195-1201.
27. Linseman, D. A., C. M. Bartley, S. S. Le, T. A. Laessig, R. J. Bouchard, M. K. Meintzer, M. Li, and K. A. Heidenreich. 2003. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+)/ calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J. Biol. Chem. 278:41472-41481.
28. Lu, J., T. A. McKinsey, R. L. Nicol, and E. N. Olson. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97:4070-4075.
29. Marks, P. A., V. M. Richon, T. Miller, and W. K. Kelly. 2004. Histone deacetylase inhibitors. Adv. Cancer Res. 91:137-168.
30. McKinsey, T. A., C. L. Zhang, J. Lu, and E. N. Olson. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-111.
31. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2000. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97:14400-14405.
32. Petrie, K., F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent. 2003. The histone deacetylase 9 gene encodes multiple protein isoforms. J. Biol. Chem. 278:16059-16072.
33. Powlesland, R. M., A. K. Charles, K. T. Malik, P. A. Reynolds, S. Pires, M. Boavida, and K. W. Brown. 2000. Loss of heterozygosity at 7p in Wilms' tumour development. Br. J. Cancer 82:323-329.
34. Resnick, L., and M. Fennell. 2004. Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discov. Today 9:932-939.
35. Rouaux, C., N. Jokic, C. Mbebi, S. Boutillier, J. P. Loeffler, and A. L. Boutillier. 2003. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 22:6537-6549.
36. Ryu, H., J. Lee, B. A. Olofsson, A. Mwidau, A. Dedeoglu, M. Escudero, E. Flemington, J. Azizkhan-Clifford, R. J. Ferrante, and R. R. Ratan. 2003. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc. Natl. Acad. Sci. USA 100:4281-4286.
37. Salminen, A., T. Tapiola, P. Korhonen, and T. Suuronen. 1998. Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res. Mol. Brain Res. 61:203-206.
38. Schmidt, H., H. Taubert, P. Wurl, M. Kappler, H. Lange, F. Bartel, M. Bache, H. J. Holzhausen, and R. Hinze. 2002. Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes Cancer 34:69-77.
39. See, V., A. L. Boutillier, H. Bito, and J. P. Loeffler. 2001. Calcium/calmodulin-dependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons. FASEB J. 15:134-144.
40. Sparrow, D. B., E. A. Miska, E. Langley, S. Reynaud-Deonauth, S. Kotecha, N. Towers, G. Spohr, T. Kouzarides, and T. J. Mohun. 1999. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18:5085-5098.
41. Stankiewicz, P., H. Thiele, C. Baldermann, A. Kruger, I. Giannakudis, S. Dorr, N. Werner, J. Kunz, G. A. Rappold, and I. Hansmann. 2001. Phenotypic findings due to trisomy 7p15.3-pter including the TWIST locus. Am. J. Med. Genet. 103:56-62.
42. Verdin, E., F. Dequiedt, and H. G. Kasler. 2003. Class II histone deacetylases: versatile regulators. Trends Genet. 19:286-293.
43. Wang, L. H., C. G. Besirli, and E. M. Johnson, Jr. 2004. Mixed-lineage kinases: a target for the prevention of neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 44:451-474.
44. Watson, A., A. Eilers, D. Lallemand, J. Kyriakis, L. L. Rubin, and J. Ham. 1998. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18:751-762.
45. Yalcin, A., E. Koulich, S. Mohamed, L. Liu, and S. R. D'Mello. 2003. Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB-binding protein and NF-kappaB. J. Neurochem. 84:397-408.
46. Yang, D. D., C. Y. Kuan, A. J. Whitmarsh, M. Rincon, T. S. Zheng, R. J. Davis, P. Rakic, and R. A. Flavell. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389:865-870.
47. Zhang, C. L., T. A. McKinsey, and E. N. Olson. 2001. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc. Natl. Acad. Sci. USA 98:7354-7359.
48. Zhou, X., V. M. Richon, R. A. Rifkind, and P. A. Marks. 2000. Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. Proc. Natl. Acad. Sci. USA 97:1056-1061.